Benzinga | Oct 29, 2020 08:54AM EDT

Raymond James Maintains Strong Buy on Viking Therapeutics, Raises Price Target to $27

Raymond James maintains Viking Therapeutics (NASDAQ:VKTX) with a Strong Buy and raises the price target from $25 to $27.